Grant: Discovery Grants Program - Individual
University of Ottawa
$31,000.00
Innate immune mechanisms coordinating hepatic metabolic homeostasis
FY 2016-17
Summary
Fundamental question: Because the liver receives blood from the gut via the portal vein, it constantly faces infectious and dietary challenges. While it is known that the liver controls metabolic homeostasis, how the liver's innate immune mechanisms affect its metabolic homeostasis have yet to be elucidated.
A recent study showed that the transcription factor MEF2 responds to infection and switches metabolism in the Drosophila fat body (liver/adipose tissue equivalent) from anabolism to catabolism. With prior NSERC support, we identified a novel MEF2 partner, IRF2BP2, and showed that it is a key innate immune regulator suppressing inflammation. Bacterial lipopolysaccharides reduce IRF2BP2 levels in hepatocyte. Thus, IRF2BP2 likely ties the innate immune axis to the control liver metabolic function.
Most IRF2BP2-deficient mice die before birth; the few that survived had severely enlarged livers. To bypass embryonic lethality, we made liver-specific knockout (LKO) mice. LKO hepatocytes have an impaired insulin response and LKO mice have elevated gluconeogenesis and are more susceptible to diet-induced liver fat accumulation (steatosis) and inflammation. Microarray analysis showed that LKO livers have: 1) increased Gbp6, 2) reduced expression of the Rae-1 ligands for natural killer T (NKT) cells, 3) reduced Cyp2C19 and Cyp2c55, genes that detoxify food-derived xenobiotics. How IRF2BP2 ties these innate immune mechanisms to influence hepatic inflammation and function (insulin sensitivity, gluconeogenesis, lipogenesis) will be addressed in the following aims:
Aim 1 : Does IRF2BP2 control Gbp6 in hepatocytes to maintain glucose homeostasis?
Gbp6 is a GTPase activated by infection to destroy intracellular bacteria. Does IRF2BP2 suppress Gbp6 expression via IRF2? MEF2? GTPases inhibit the response to insulin; does blocking Gbp6 expression in LKO hepatocytes improve insulin signaling to suppress gluconeogenesis?
Aim 2: Does IRF2BP2 promote NKT cell recruitment/activity to maintain hepatic function?
Rae-1 ligands bind, recruit and/or activate NKT cells. NKT cell recruitment helps to maintain hepatic insulin sensitivity and prevents steatosis. Does IRF2BP2 promote Rae-1 expression via MEF2 to recruit hepatic NKT cells? Can restoring Rae-1 in LKO livers improve NKT cell recruitment/activity and hepatic function?
Aim 3: Does IRF2BP2 promote xenobiotic detoxification?
Does IRF2BP2 activate Cyp2C29 and Cyp2C55 genes through MEF2? Cyp2C29 and Cyp2C55 generate anti-inflammatory epoxyeicosatrienoic acids (EET) that promote hepatic insulin sensitivity. Can restoring Cyp2C29 and Cyp2C55 reduce inflammation and protect against xenobiotics?
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2016-04985
Name nom
Stewart, Alexandre
Department département
Biochemistry, Microbiology and Immunology - Biochimie, microbiologie et immunolo
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
31000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Partie
1
Nb partie
5
Application title
Innate immune mechanisms coordinating hepatic metabolic homeostasis
Keyword
NSERC
Application summary
Fundamental question: Because the liver receives blood from the gut via the portal vein, it constantly faces infectious and dietary challenges. While it is known that the liver controls metabolic homeostasis, how the liver's innate immune mechanisms affect its metabolic homeostasis have yet to be elucidated.
A recent study showed that the transcription factor MEF2 responds to infection and switches metabolism in the Drosophila fat body (liver/adipose tissue equivalent) from anabolism to catabolism. With prior NSERC support, we identified a novel MEF2 partner, IRF2BP2, and showed that it is a key innate immune regulator suppressing inflammation. Bacterial lipopolysaccharides reduce IRF2BP2 levels in hepatocyte. Thus, IRF2BP2 likely ties the innate immune axis to the control liver metabolic function.
Most IRF2BP2-deficient mice die before birth; the few that survived had severely enlarged livers. To bypass embryonic lethality, we made liver-specific knockout (LKO) mice. LKO hepatocytes have an impaired insulin response and LKO mice have elevated gluconeogenesis and are more susceptible to diet-induced liver fat accumulation (steatosis) and inflammation. Microarray analysis showed that LKO livers have: 1) increased Gbp6, 2) reduced expression of the Rae-1 ligands for natural killer T (NKT) cells, 3) reduced Cyp2C19 and Cyp2c55, genes that detoxify food-derived xenobiotics. How IRF2BP2 ties these innate immune mechanisms to influence hepatic inflammation and function (insulin sensitivity, gluconeogenesis, lipogenesis) will be addressed in the following aims:
Aim 1 : Does IRF2BP2 control Gbp6 in hepatocytes to maintain glucose homeostasis?
Gbp6 is a GTPase activated by infection to destroy intracellular bacteria. Does IRF2BP2 suppress Gbp6 expression via IRF2? MEF2? GTPases inhibit the response to insulin; does blocking Gbp6 expression in LKO hepatocytes improve insulin signaling to suppress gluconeogenesis?
Aim 2: Does IRF2BP2 promote NKT cell recruitment/activity to maintain hepatic function?
Rae-1 ligands bind, recruit and/or activate NKT cells. NKT cell recruitment helps to maintain hepatic insulin sensitivity and prevents steatosis. Does IRF2BP2 promote Rae-1 expression via MEF2 to recruit hepatic NKT cells? Can restoring Rae-1 in LKO livers improve NKT cell recruitment/activity and hepatic function?
Aim 3: Does IRF2BP2 promote xenobiotic detoxification?
Does IRF2BP2 activate Cyp2C29 and Cyp2C55 genes through MEF2? Cyp2C29 and Cyp2C55 generate anti-inflammatory epoxyeicosatrienoic acids (EET) that promote hepatic insulin sensitivity. Can restoring Cyp2C29 and Cyp2C55 reduce inflammation and protect against xenobiotics?